CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin
June 02, 2010
CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin
The 13 drugs for which CVS Caremark customers will have the option to sign up for genetic testing includes a range of treatments for cancer, HIV, and other indications, but the anticoagulant warfarin is not on the list.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan
July 27, 2011 / Pharmacogenomics Reporter - Medco to Expand PGx Offerings to All Clients in July
May 26, 2010 / Pharmacogenomics Reporter - Buying Remaining Stake in Generation Health, CVS Caremark Keeps PGx Programs but Cuts Staff
August 29, 2012 / Pharmacogenomics Reporter - New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx
August 29, 2012 / Pharmacogenomics Reporter - Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
May 9, 2012 / Pharmacogenomics Reporter